ZW792A1 - Chemical process - Google Patents

Chemical process

Info

Publication number
ZW792A1
ZW792A1 ZW7/92A ZW792A ZW792A1 ZW 792 A1 ZW792 A1 ZW 792A1 ZW 7/92 A ZW7/92 A ZW 7/92A ZW 792 A ZW792 A ZW 792A ZW 792 A1 ZW792 A1 ZW 792A1
Authority
ZW
Zimbabwe
Prior art keywords
chemical process
chemical
Prior art date
Application number
ZW7/92A
Inventor
Peter Thomas Andrew
Arnold Lee Stanley
Michael Glanville Martin David
Powell Lyn
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919101026A external-priority patent/GB9101026D0/en
Priority claimed from GB919106876A external-priority patent/GB9106876D0/en
Priority claimed from GB919121726A external-priority patent/GB9121726D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of ZW792A1 publication Critical patent/ZW792A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZW7/92A 1991-01-17 1992-01-13 Chemical process ZW792A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919101026A GB9101026D0 (en) 1991-01-17 1991-01-17 Chemical process
GB919106876A GB9106876D0 (en) 1991-04-02 1991-04-02 Manufacturing process
GB919121726A GB9121726D0 (en) 1991-10-14 1991-10-14 Process

Publications (1)

Publication Number Publication Date
ZW792A1 true ZW792A1 (en) 1992-09-30

Family

ID=27265456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW7/92A ZW792A1 (en) 1991-01-17 1992-01-13 Chemical process

Country Status (15)

Country Link
US (2) US5294716A (en)
EP (1) EP0495626A1 (en)
JP (1) JPH0559042A (en)
KR (1) KR920014800A (en)
AU (1) AU9012091A (en)
CA (1) CA2058899A1 (en)
CS (1) CS9992A3 (en)
FI (1) FI920212A (en)
GB (1) GB9200758D0 (en)
HU (1) HUT60262A (en)
IE (1) IE914572A1 (en)
IL (1) IL100580A0 (en)
NO (1) NO920222L (en)
PT (1) PT100022A (en)
ZW (1) ZW792A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5602127A (en) * 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5614519A (en) * 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
US5594003A (en) * 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5252753A (en) * 1991-11-01 1993-10-12 Ortho Pharmaceutical Corporation Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof
ES2203614T3 (en) * 1991-11-18 2004-04-16 E.I. Du Pont De Nemours And Company TETRAZOLILPHENILBORONIC ACID INTERMEDIATES FOR SYNTHESIS OF ANTAGONISTS OF AII RECEIVERS.
GB9201715D0 (en) * 1992-01-28 1992-03-11 Ici Plc Chemical process
CA2111662C (en) * 1992-12-17 2004-11-23 Hiroaki Yanagisawa Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
EP1438973A4 (en) * 2001-10-05 2005-07-13 Ono Pharmaceutical Co Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
CA2482857A1 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Processes for preparing losartan and losartan potassium
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
KR100953878B1 (en) * 2004-09-02 2010-04-22 테바 파마슈티컬 인더스트리즈 리미티드 Purification of olmesartan medoxomil
CN1976926A (en) * 2004-09-02 2007-06-06 特瓦制药工业有限公司 Preparation of olmesartan medoxomil
US20060258727A1 (en) * 2005-01-03 2006-11-16 Lilach Hedvati Olmesartan medoxomil with reduced levels of impurities
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2828764A1 (en) * 2011-03-03 2012-09-07 Treventis Corporation Anti-amyloid compounds and methods
JP6151775B2 (en) 2012-06-25 2017-06-21 サニオナ・エイピイエス Novel tetrazole derivatives and their use as potassium channel modulators
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
BR112015030326A2 (en) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc ULTRAPURE GUANYLATE CYCLASE C AGONISTS, METHOD OF MANUFACTURING AND USING THEM
EP3902787A4 (en) * 2018-12-28 2022-12-28 Riboscience LLC Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69016125T2 (en) * 1989-08-11 1995-06-01 Zeneca Ltd Quinoline derivatives, processes for their preparation and their use as medicines.
GB2244054B (en) * 1990-04-19 1994-04-06 Ici Plc Pyridine derivatives
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5252753A (en) * 1991-11-01 1993-10-12 Ortho Pharmaceutical Corporation Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Also Published As

Publication number Publication date
FI920212A0 (en) 1992-01-17
NO920222L (en) 1992-07-20
KR920014800A (en) 1992-08-25
PT100022A (en) 1993-02-26
FI920212A (en) 1992-07-18
HUT60262A (en) 1992-08-28
CS9992A3 (en) 1992-08-12
NO920222D0 (en) 1992-01-16
GB9200758D0 (en) 1992-03-11
US5420292A (en) 1995-05-30
CA2058899A1 (en) 1992-07-18
IL100580A0 (en) 1992-09-06
IE914572A1 (en) 1992-07-29
EP0495626A1 (en) 1992-07-22
US5294716A (en) 1994-03-15
JPH0559042A (en) 1993-03-09
HU9200130D0 (en) 1992-04-28
AU9012091A (en) 1992-07-23

Similar Documents

Publication Publication Date Title
GB9105167D0 (en) Chemical process
GB9107124D0 (en) Chemical process
IL100580A0 (en) Chemical process
GB9126339D0 (en) Chemical process
GB9125116D0 (en) Chemical process
GB9121656D0 (en) Chemical process
GB9222619D0 (en) Chemical process
GB9211793D0 (en) Chemical process
GB9105166D0 (en) Chemical process
GB9101026D0 (en) Chemical process
GB9111394D0 (en) Chemical process
GB9112833D0 (en) Chemical process
GB9103654D0 (en) Chemical process
GB9112861D0 (en) Chemical process
GB9113911D0 (en) Chemical process
GB9113914D0 (en) Chemical process
GB9118198D0 (en) Chemical process
GB9118222D0 (en) Chemical process
GB9122875D0 (en) Chemical process
GB9112817D0 (en) Chemical process
GB9112860D0 (en) Chemical process
GB9112187D0 (en) Chemical process
GB9123268D0 (en) Chemical process
GB9126330D0 (en) Chemical process
GB9112140D0 (en) Chemical process